本页面由Tiger Trade Technology Pte. Ltd.提供服务

Atea Pharmaceuticals, Inc.

3.20
0.0000
成交量:14.41万
成交额:45.66万
市值:2.50亿
市盈率:-1.81
高:3.21
开:3.21
低:3.11
收:3.20
52周最高:4.02
52周最低:2.46
股本:7,812.68万
流通股本:6,000.97万
量比:0.61
换手率:0.24%
股息:- -
股息率:- -
每股收益(TTM):-1.7696
每股收益(LYR):-1.9983
净资产收益率:-37.98%
总资产收益率:-23.86%
市净率:0.79
市盈率(LYR):-1.60

数据加载中...

2024/09/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/06/21

重要事件披露

Form 8-K - Current report
2024/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities